The vaccine, based on a genetically modified cold virus, was developed in the lab of Zhou Xing,professor of pathology and molecular medicine and the McMaster Immunology Research Centre, who co-led the phase one study with Dr. Fiona Smaill, professor and chair of theDepartment of Pathology and Molecular Medicine of the Michael G. DeGroote School of Medicine at McMaster.
The new vaccine was developed to act as a booster to Bacille Calmette Guerin (BCG), currently the only TB vaccine available.
BCG was developed in the 1920s and has been used worldwide. The new “booster” would reactivate immune elements that over time diminish following BCG vaccination.
The findings have been published in the journal Science Translational Medicine.
Gideon
October 3, 2013 at 1:57 pm
Good woork professors.
Dave Michaels
October 3, 2013 at 3:50 pm
Cancer and High Blood Pressure related conditions. Call 0979546725 and enquire about Stemtech Medication. For Manhood problems? Ask for Python medication. All meds are imported from South Africa. Works a 100%
MundiaM
October 3, 2013 at 3:56 pm
All in Africa will surely need this vaccine. Thank you doctors.
roga roga
October 3, 2013 at 10:26 pm
Uyu chikala Michael. Stop your bullshit adds stanina. Nkakutombela abakashi pushi.
Medication
October 4, 2013 at 8:19 am
Cancer and High Blood Pressure related conditions. Call 0979546725 and enquire about Stemtech Medication. For Manhood problems? Ask for Python medication. All meds are imported from South Africa. Works a 100%
Kasenge Richard
October 5, 2013 at 9:20 am
I would berg the pipo in charge to speed up the process so that TB patients can access the Vaccines as early as possible.LIFE IS PRECIOUS for none can buy life at the Market.